Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Warfarin, acetylsalicylic acid and risk of incident atrial fibrillation in patients with heart failure and sinus rhythm: a meta-analysis.

Caldeira D, Fernandes RM, David C, Costa J, Ferreira JJ.

Int J Cardiol. 2013 Oct 12;168(5):4842-3. doi: 10.1016/j.ijcard.2013.07.033. Epub 2013 Jul 23. No abstract available.

PMID:
23886535
2.

Warfarin may reduce risk of ischemic stroke by preventing atrial fibrillation for patients with heart failure and sinus rhythm.

Lin GM, Li YH, Jaiteh LE, Han CL.

Int J Cardiol. 2013 Apr 5;164(2):245-6. doi: 10.1016/j.ijcard.2012.06.080. Epub 2012 Jul 12. No abstract available.

PMID:
22795713
3.

Is risk-benefit of warfarin for atrial fibrillation with heart failure determined by heart failure severity?

Sindone AP, Freedman SB.

Thromb Haemost. 2015 Jul;114(1):1-3. doi: 10.1160/TH15-04-0297. Epub 2015 May 7. No abstract available.

PMID:
25947352
4.

Stroke in heart failure in sinus rhythm: the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial.

Pullicino PM, Thompson JL, Sacco RL, Sanford AR, Qian M, Teerlink JR, Haddad H, Diek M, Freudenberger RS, Labovitz AJ, Di Tullio MR, Lok DJ, Ponikowski P, Anker SD, Graham S, Mann DL, Mohr JP, Homma S; WARCEF Investigators.

Cerebrovasc Dis. 2013;36(1):74-8. doi: 10.1159/000352058. Epub 2013 Jul 30.

5.

[Prevention of ischemic stroke in middle aged patients with atrial fibrillation. Effect of sinus rhythm maintenance, aspirin, warfarin, and simvastatin].

Kanorskiĭ SG, Shevelev VI, Zafiraki VK, Zingilevskiĭ KB.

Kardiologiia. 2007;47(1):26-30. Russian.

PMID:
17426677
6.

Anti-thrombotic strategies for patients with atrial fibrillation and heart failure.

Walsh MN, Prystowsky EN.

Heart Fail Rev. 2002 Jul;7(3):261-6. Review.

PMID:
12215731
7.

Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysis.

Agarwal S, Hachamovitch R, Menon V.

Arch Intern Med. 2012 Apr 23;172(8):623-31; discussion 631-3. doi: 10.1001/archinternmed.2012.121. Epub 2012 Mar 26. Review.

PMID:
22450212
8.

Stroke in heart failure: atrial fibrillation revisited?

Pullicino P, Homma S.

J Stroke Cerebrovasc Dis. 2010 Jan;19(1):1-2. doi: 10.1016/j.jstrokecerebrovasdis.2009.09.002. No abstract available.

PMID:
20123219
9.

Benefit of warfarin compared with aspirin in patients with heart failure in sinus rhythm: a subgroup analysis of WARCEF, a randomized controlled trial.

Homma S, Thompson JL, Sanford AR, Mann DL, Sacco RL, Levin B, Pullicino PM, Freudenberger RS, Teerlink JR, Graham S, Mohr JP, Massie BM, Labovitz AJ, Di Tullio MR, Gabriel AP, Lip GY, Estol CJ, Lok DJ, Ponikowski P, Anker SD; WARCEF Investigators.

Circ Heart Fail. 2013 Sep 1;6(5):988-97. doi: 10.1161/CIRCHEARTFAILURE.113.000372. Epub 2013 Jul 23.

10.

Quality of care for atrial fibrillation among patients hospitalized for heart failure.

Piccini JP, Hernandez AF, Zhao X, Patel MR, Lewis WR, Peterson ED, Fonarow GC; Get With The Guidelines Steering Committee and Hospitals.

J Am Coll Cardiol. 2009 Sep 29;54(14):1280-9. doi: 10.1016/j.jacc.2009.04.091.

11.

Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation.

Winkelmayer WC, Liu J, Setoguchi S, Choudhry NK.

Clin J Am Soc Nephrol. 2011 Nov;6(11):2662-8. doi: 10.2215/CJN.04550511. Epub 2011 Sep 29.

12.

Risk-benefit profile of warfarin versus aspirin in patients with heart failure and sinus rhythm: a meta-analysis.

Lee M, Saver JL, Hong KS, Wu HC, Ovbiagele B.

Circ Heart Fail. 2013 Mar;6(2):287-92. doi: 10.1161/CIRCHEARTFAILURE.112.971697. Epub 2012 Dec 21. Review.

13.

Underuse of antithrombotic therapy caused high incidence of ischemic stroke in patients with atrial fibrillation.

Yu HC, Tsai YF, Chen MC, Yeh CH.

Int J Stroke. 2012 Feb;7(2):112-7. doi: 10.1111/j.1747-4949.2011.00667.x. Epub 2011 Nov 22.

PMID:
22103748
15.
16.

Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study.

Sherman DG, Kim SG, Boop BS, Corley SD, Dimarco JP, Hart RG, Haywood LJ, Hoyte K, Kaufman ES, Kim MH, Nasco E, Waldo AL; National Heart, Lung, and Blood Institute AFFIRM Investigators.

Arch Intern Med. 2005 May 23;165(10):1185-91.

PMID:
15911734
17.

Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: a subgroup analysis of the RE-LY trial.

Ferreira J, Ezekowitz MD, Connolly SJ, Brueckmann M, Fraessdorf M, Reilly PA, Yusuf S, Wallentin L; RE-LY Investigators.

Eur J Heart Fail. 2013 Sep;15(9):1053-61. doi: 10.1093/eurjhf/hft111. Epub 2013 Jul 9.

18.

Temporal trends in ischemic stroke and anticoagulation therapy among Medicare patients with atrial fibrillation: a 15-year perspective (1992-2007).

Shroff GR, Solid CA, Herzog CA.

JAMA Intern Med. 2013 Jan 28;173(2):159-60. doi: 10.1001/jamainternmed.2013.1579. No abstract available.

PMID:
23266657
19.

Does warfarin help prevent ischemic stroke in patients presenting with post coronary bypass paroxysmal atrial fibrillation?

Hata M, Akiyama K, Wakui S, Takasaka A, Sezai A, Shiono M.

Ann Thorac Cardiovasc Surg. 2013;19(3):207-11. Epub 2012 Aug 20.

20.

Efficacy and safety of warfarin vs. antiplatelet therapy in patients with systolic heart failure and sinus rhythm: a systematic review and meta-analysis of randomized controlled trials.

Liew AY, Eikelboom JW, Connolly SJ, O' Donnell M, Hart RG.

Int J Stroke. 2014 Feb;9(2):199-206. doi: 10.1111/ijs.12036. Epub 2013 Mar 19. Review.

PMID:
23506160
Items per page

Supplemental Content

Write to the Help Desk